Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

AI could help rescuers push in the right spot during CPR

NCT ID NCT07431710

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests an AI system that reads blood pressure signals during CPR to tell rescuers if they are compressing the wrong part of the chest. In about half of cardiac arrest patients, standard chest compressions accidentally press on a valve in the heart, reducing blood flow. The AI aims to guide rescuers to adjust their hand position for better results. The trial will enroll 255 adults with out-of-hospital cardiac arrest to see if the AI can accurately detect this problem and help rescuers fix it quickly.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
AI-Enhanced Arterial Waveform Monitor (AIR-CPR App)
What this could lead to
If successful, this could lead to a simple AI tool that helps rescuers personalize CPR, potentially improving survival from cardiac arrest.
What could go wrong
This is an early-stage study focused on accuracy and feasibility, not yet on survival outcomes. The AI may not work in all patients, and adjusting compressions could delay care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 255 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2025

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population consists of adult patients experiencing non-traumatic out-of-hospital cardiac arrest who are transported to the Emergency Department of Far Eastern Memorial Hospital. This facility is the only medical center in New Taipei City and handles approximately 30% of the city's OHCA cases, ensuring a diverse and high-volume sample of patients receiving advanced life support.

Ages

20 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Adults aged 20 years or older. 2. Patients with out-of-hospital cardiac arrest (OHCA) undergoing 3.cardiopulmonary resuscitation (CPR) in the emergency department. Cardiac arrest caused by non-traumatic factors. Exclusion Criteria: 1. Pregnant patients. 2. Patients with obvious signs of death. 3. Patients with a signed "Do Not Resuscitate" (DNR) order. 4. Patients requiring extracorporeal cardio-pulmonary resuscitation (ECPR). 5. Patients requiring Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA). 6. Cardiac arrest caused by massive hemorrhage, aortic emergencies, tension pneumothorax, cardiac tamponade, or pulmonary embolism. 7. History of severe aortic valve disease or previous aortic valve surgery. 8. Patients for whom TEE or femoral arterial catheterization is contraindicated. 9. Situations where the medical team is unable to perform TEE or femoral arterial catheterization during CPR.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Aortic valve compression are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cardiac arrest Out-of-Hospital Cardiac Arrest sudden cardiac arrest

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Far Eastern Memorinal Hospital

    RECRUITING

    New Taipei City, Banqiao, 220, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.